Physician profile
Thomas Reisman
NPI 1720028756
$5,645.23
in general payments reported to CMS, 2019-2025
34 companies · $1,045 in 2025
The $1,045 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,501 · 2020: $481 · 2021: $155 · 2022: $131 · 2023: $699 · 2024: $1,634 · 2025: $1,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,378.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $899.26 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $891.58 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $868.17 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $717.98 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $360.82 | 2019-2024 | |
| Eisai INC. | $190.16 | 2024-2025 | |
| Renalytix Ai, INC. | $184.00 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Atricure, INC. | $164.02 | 2020-2023 | |
| Pfizer INC. | $127.76 | 2019-2024 | |
| Amgen INC. | $124.77 | 2019 | |
| Celgene Corporation | $123.47 | 2019 | |
| Ucb, INC. | $122.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $108.27 | 2022-2024 | |
| Insightec,INC | $105.93 | 2025 | Exablate |
| Echosens North America, INC. | $94.32 | 2025 | Fibroscan |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $63.07 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $52.07 | 2023-2024 | Nexletol |
| Bausch Health US, LLC | $52.01 | 2024-2025 | Aplenzin |
| Exact Sciences Corporation | $38.27 | 2023-2024 | Cologuard Collection Kit |
| Corcept Therapeutics | $35.74 | 2025 | Korlym |
| Madrigal Pharmaceuticals | $34.49 | 2025 | Rezdiffra |
| Merck Sharp & Dohme LLC | $30.66 | 2019 | |
| Alexion Pharmaceuticals, INC. | $28.10 | 2024 | Strensiq |
| Acella Pharmaceuticals, LLC | $25.94 | 2024 | NP Thyroid 60 |
| Kowa Pharmaceuticals America, INC. | $25.37 | 2022 | |
| Abbott Laboratories | $24.92 | 2023 | Freestyle Libre 3 |
| Shield Therapeutics INC | $22.02 | 2023 | Accrufer |
| Azurity Pharmaceuticals, INC. | $20.54 | 2023 | Adthyza |
| Medtronic, INC. | $20.48 | 2023 | Linq II |
| Heartflow, INC. | $19.83 | 2025 | |
| Xeris Pharmaceuticals, INC. | $19.38 | 2025 | Gvoke Hypopen |
| Boston Scientific Corporation | $17.47 | 2024 | Varithena Administration Pack |
| Sanofi Pasteur INC. | $16.94 | 2020 | |
| Philips North America LLC | $14.90 | 2024 | (5044) Mcot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Reisman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.